Search clinical trials for: Rosuvastatin/Valsartan

Total 1143 results

AstraZeneca

Completed

Study to Compare the Bioavailability of ABT-335 and Rosuvastatin From ABT-143 Relative to That From the Co-administration of ABT-335 and Rosuvastatin Calcium

Adverse Events | Pharmacokinetic

United States
AstraZeneca

Completed

Comparison of the Bioavailability of Fenofibric Acid and Rosuvastatin From ABT-143 Relative to That From the Coadministration of ABT-335 (Fenofibric Acid) and Rosuvastatin Calcium

Healthy

United States
AstraZeneca

Completed

Dutch Sub Study: Controlled Rosuvastatin Multinational Study in Heart Failure (CORONA). PET Sub Study

Heart Failure | Rosuvastatin | Positron Emission Tomography (PET)

Netherlands
Universidad Autonoma de San Luis Potosí
AstraZeneca; Hospital Central "Dr. Ignacio Morones Prieto"

Completed

Effect of Rosuvastatin on Amnesia and Orientation Through Galveston Outcome Amnesia Test in Moderate Head Injury

Head Injury

Mexico
AstraZeneca

Completed

Effects of Crestor on Inflammation of Atherosclerotic Plaques

Atherosclerosis | Inflammatory Activity in Carotid Arteries

Sweden
AstraZeneca

Completed

Compare the Safety & Efficacy of Rosuvastatin 40mg in Combination With Ezetimibe 10mg (EXPLORER)

Atherosclerosis | Hypercholesterolemia | Coronary Heart Disease
AstraZeneca

Completed

Evaluation of Effects of Rosuvastatin 40mg on Myocardial Ischemia in Subjects With Coronary Artery Disease

Coronary Artery Disease | Myocardial Ischaemia
Brigham and Women's Hospital

Completed

Rho Kinase in Patients With Atherosclerosis

Atherosclerosis

United States
Washington University School of Medicine

Recruiting

Statins in Patients With Clonal Cytopenia of Undetermined Significance (CCUS) and Myelodysplastic Syndromes (MDS)

Myelodysplastic Syndromes | Clonal Cytopenia of Undetermined Significance

United States
Loxo Oncology, Inc.
Eli Lilly and Company

Completed

A Drug Drug Interaction (DDI) Study of Pirtobrutinib (LY3527727) and Rosuvastatin in Healthy Participants

Healthy

United States
Minneapolis Heart Institute Foundation

Active, not recruiting

The DEtermining Statin Intolerance FOr Rosuvastatin (DESIFOR) Trial (DESIFOR)

Cardiovascular Diseases | Cardiovascular Risk Factor | Adverse Effect

United States
Helse Stavanger HF
University Hospital of North Norway; St. Olavs Hospital; Helse Vest

Completed

Microcirculation In Acute Coronary Syndromes (MICROS)

ST Elevation (STEMI) Myocardial Infarction

Norway
AstraZeneca

Completed

A phase3 Study Measuring the Effect of Rosuvastatin 20 mg on Carotid Intima-Media Thickness in Chinese Subjects With Subclinical Atherosclerosis

Atherosclerosis

China
Children's Mercy Hospital Kansas City

Completed

Pharmacokinetics of Rosuvastatin and Atorvastatin in Pediatric Dyslipidemia Patients (SD2)

Dyslipidemia

United States
Poxel SA

Completed

Safety, Tolerability and PK of PXL770 in Healthy Male Subjects

Metabolic Disease

United Kingdom
University of Vermont

Completed

Detecting the Impact of Statin Therapy On Lowering Risk of Venous Thrombo-Embolic Events (DISOLVE) (DISOLVE)

Neoplasms | Deep Vein Thrombosis | Venous Thromboembolism

United States
AstraZeneca

Completed

A Study to Evaluate the Efficacy and Safety of Rosuvastatin in Children and Adolescents With Homozygous Familial Hypercholesterolemia (HYDRA)

Homozygous Familial Hypercholesterolemia (HoFH)

Malaysia, Canada, Israel, Netherlands, Taiwan, Belgium, Denmark
Queen's University
AstraZeneca

Completed

Comparison of Rosuvastatin and Atorvastatin in Patients With Acute Coronary Syndrome

Dyslipidemia | Acute Coronary Syndromes

Canada
Listen Trial Group

Completed

LIpid Lowering With Highly Potent Statins in Hyperlipidaemia With Type 2 Diabetes patiENts (LISTEN)

Hypercholesterolemia With Concomitant Type 2 Diabetes

Japan
Svendborg Hospital
University of Southern Denmark

Unknown

Intensive Statin Therapy in Patients With AMI (INTENSIFY)

Acute Myocardial Infarction

Denmark
AstraZeneca

Completed

Compare the Efficacy of Rosuvastatin to Atorvastatin in High Risk Patients With Hypercholesterolemia

Hypercholesterolemia

China
University of Rome Tor Vergata

Completed

Metabolic and Vascular Effects of Statins in Untreated Dyslipidemic Diabetic Patients

Type 2 Diabetes | Diabetic Dyslipidemia

Italy
AstraZeneca

Completed

IIIb 6 Week Open Label Multicentre Rosuvastatin & Simvastatin

Fredrickson Type IIa & Type IIb Dyslipidaemia
AstraZeneca

Completed

Effects in The ApoB/ApoA-I Ratio Using Rosuvastatin and Atorvastatin in Patients With Acute Coronary Syndrome

Acute Coronary Syndrome

France, Italy, Spain, Estonia, Hungary, Canada, Belgium, Portugal, Greece, Ireland, Tunisia
Hanlim Pharm. Co., Ltd.

Unknown

To Evaluate the Efficacy and Safety of Co-administrated Ezetimibe/Rosuvastatin and Telmisartan in Patients With Essential Hypertension and Primary Hypercholesterolemia

Hypertension | Primary Hypercholesterolemia

Korea, Republic of
Boryung Pharmaceutical Co., Ltd

Completed

A Study to Compare the Pharmacokinetics and Safety of a Fixed Dose Combination of Fimasartan/Amlodipine/Rosuvastatin

Hypertension | Hyperlipidemia

Korea, Republic of
Universidade Federal do Rio Grande do Norte
University of Sao Paulo

Completed

Zinc and Selenium Supplementation in Atherosclerosis

Dietary Zinc Deficiency | Dietary Selenium Deficiency

Brazil
Canadian Network for Observational Drug Effect...
Canadian Institutes of Health Research (CIHR); Drug Safety and Effectiveness...

Completed

High Potency Statins and the Risk of Diabetes (Statins-DM)

Cardiovascular Disease | Diabetes Mellitus, Type 2
Boehringer Ingelheim

Completed

A Study in Healthy Men to Test the Influence of BI 1323495 on the Amount of the Medicines Rosuvastatin and Dabigatran in the Blood

Healthy

Germany
Jeil Pharmaceutical Co., Ltd.

Completed

Clinical Trial to Investigate the Pharmacokinetics Drug Interaction Between Metformin and Rosuvastatin

Diabetes | Hyperlipidemia

Korea, Republic of
Seung-Jung Park
CardioVascular Research Foundation, Korea

Completed

Statin and Atheroma Vulnerability Evaluation (STABLE)

Coronary Artery Disease

Korea, Republic of
Yuhan Corporation

Completed

Efficacy and Safety Study of YH16410 Versus Rosuvastatin and Telmisartan Monotherapies in Patients With Hypertension and Hyperlipidemia

Hypertension | Hyperlipidemia

Korea, Republic of
Merck Sharp & Dohme LLC
Centocor, Inc.

Completed

Investigation of 9 Consecutive Infusions of Remicade for Psoriatic Arthritis in Austria (Study P04264)

Arthritis, Psoriatic
Brigham and Women's Hospital

Active, not recruiting

Prospective Monitoring of Angiotensin Receptor Neprilysin Inhibitor in Older Adults With Heart Failure and Frailty

Frailty | Heart Failure, Systolic

United States
Cairo University
German University in Cairo

Recruiting

Evaluation of the Effect of Rosuvastatin on Cisplatin-induced Nephrotoxicity and Ototoxicity

Cisplatin Adverse Reaction

Egypt
Bjarne Linde Noergaard

Recruiting

Influence of Intensive Lipid-lowering on FFRCT (The FLOW-PROMOTE Study) (FlowPromote)

Coronary Artery Disease

Denmark
Asan Medical Center
Dong-A ST Co., Ltd.

Completed

Effect of Rosuvastatin on Coronary Flow Reserve in Hypertensive Patients With Cardiovascular Risk (RESERVE II)

Hypertension

Korea, Republic of
Pfizer

Completed

A Drug-Drug Interaction Study To Estimate The Effect Of Tafamidis On Rosuvastatin Pharmacokinetics

Healthy Volunteers

Belgium
AstraZeneca
Eli Lilly and Company

Completed

A Study of Lanabecestat (LY3314814) in Healthy Participants When Taken With Rosuvastatin

Healthy

United States
National Cheng-Kung University Hospital

Completed

Vascular Protective Effect of Rosuvastatin in Arteriovenous Fistula

Diabetes Mellitus | Arteriovenous Fistula | End-stage Kidney Disease

Taiwan
GlaxoSmithKline

Completed

A Study to Investigate the Interaction of GSK1292263 With Rosuvastatin and Simvastatin in Healthy Subjects

Diabetes Mellitus, Type 2

United States
LG Life Sciences

Completed

Gemigliptin-Rosuvastatin Fix-dose Combination Phase 3(BALANCE)

Type 2 Diabetes | Dyslipidemia

Korea, Republic of
RenJi Hospital

Unknown

Exploratory Study on the Effects of Early Rosuvastatin Treatment in Patients With Acute Ischemic Stroke (AIS)

Ischemic
Pin Siang Medical Biotechnology Co., Ltd.

Unknown

A Study to Evaluate the Efficacy and Safety of Rosuvastatin in Hypercholesterolemia.

Hypercholesterolemia

Taiwan
Peking University Third Hospital

Unknown

Peking and Rotterdam on Mission to Reduce Coronary Artery Disease (PROMISS)

Diabetes Mellitus | Acute Coronary Syndrome

China
AstraZeneca

Completed

Prospective Evaluation of Proteinuria and Renal Function in Non-diabetic Patients With Progressive Renal Disease (PLANET II)

Hyperlipidemia

United States, Bulgaria, South Africa, Germany, Hungary, Romania, Canada, Denmark, Mexico, Italy, Brazil
Yokohama City University Medical Center

Unknown

The Effects of Pravastatin and Rosuvastatin on Coronary Plaques in Patients With Stable Angina Pectoris

Coronary Disease | Hypercholesterolemia

Japan
Universidad Autonoma de San Luis Potosí

Unknown

Effect of Rosuvastatin in Abdominal Sepsis

Sepsis

Mexico
AstraZeneca

Completed

Direct Statin Comparison of LDL-C Values: an Evaluation of Rosuvastatin Therapy

Hypercholesteremia

Belgium
Universidad Autonoma de San Luis Potosí

Completed

Effect of Rosuvastatin in Intracerebral Hemorrhage

Stroke | Intracerebral Hemorrhage

Mexico

3

Subscribe